Advertisement
Advertisement

CYTO

CYTO logo

Altamira Therapeutics Ltd

0.42
USD
+0.0096
+2.34%
Dec 18, 14:34 UTC -5
Open

Altamira Therapeutics Ltd Profile

About

Altamira Therapeutics Ltd. is dedicated to developing therapeutics which addresses unmet medical needs. The Company is currently active in the development of RNA therapeutics for extrahepatic therapeutic targets, nasal sprays for protection against airborne viruses and allergens or the treatment of vertigo and the development of therapeutics for intratympanic treatment of tinnitus or hearing loss. Altamira Therapeutics Ltd., formerly known as Auris Medical Holding Ltd., is headquartered in Hamilton, Bermuda.

Info & Links

CEO

Thomas Meyer

Headquarters

CLARENDON HOUSE, 2 CHURCH STREET
HAMILTON, D0 HM 11, BERMUDA

Auditor

Deloitte AG

Share holders

6

Employees

17

Altamira Therapeutics Ltd Statistics

Valuation Measures

Market Capitalization2

1.43M

Enterprise Value

1.36M

Enterprise Value/EBITDA(ttm)

--

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.15

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

0.00%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

0.00

Net Income Available to Common(ttm)

0.00

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

1.80

52-Week Change

-93.10%

S&P 500 52-Week Change

26.36%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

2.96M

% Held by Insiders

13.03%

% Held by Institutions

1.91%

Balance Sheet

Total Cash(mrq)

--

Total Cash Per Share(mrq)

--

Total Debt(mrq)

--

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement